Views & Analysis | Perspectives on pharma industry issues

R&D

A certificate of analysis should be evidence, not a sales do...

Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.

R&D

From phase 1 to phase 3: Scaling radiopharmaceutical trials

Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.

Patients

pharmaphorum podcast Episode 285, Donna Cryer, CryerHealth, LLC

Patients not just at the table, but creating their own: In c...

Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.

R&D

Gravity is an experimental variable pharma has rarely been a...

Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.

Articles

Social media challenges and benefits for pharmaceutical comp...

Rodica Ceslov shares the challenges and benefits of using social media in the pharmaceutical industry. Social media continues to have an impact on everyday life and especially in the business sector where it has changed marketing strategies and has been…

Articles

Social media in the pharmaceutical industry 2012

Hannah Blake discusses some of the topics raised at the recent ‘social media in the pharmaceutical industry’ conference. Social media is considered a “hot topic” at the moment, especially in the pharmaceutical industry. From the ever-evolving social networking sites...

Articles

Are mobile apps an opportunity for pharma? Not likely.

In our busy lives it seems we don’t have the time to learn new apps, explains Rich Meyer, so is there any point in adding to the wealth of apps available by introducing new health apps? Not right now, thinks Rich, and here’s why. There has been a lot of talk about mobile health and mobile apps but the reality is that mobile apps for smartphones are way at the...

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.

Digital